Hesperidin supplement for multiple sclerosis
Part of Brain & nervous system, Immune system & allergy clinical trials.
This study tests whether a natural supplement called hesperidin (found in citrus fruits) can help people with MS. It aims to see if it is safe and well-tolerated.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with multiple sclerosis (MS).
- You are 18 years old or older.
- You do not have food allergies, intolerances, or major stomach or bowel problems.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether taking a DHA supplement (a type of omega-3 fat) can help people with multiple sclerosis. It aims to see if it may improve muscle function or overall well-being.
This study tests whether adding a probiotic supplement to your usual MS treatment (or to no treatment) can help manage relapsing-remitting multiple sclerosis. It aims to see if the probiotic is safe and beneficial as an add-on therapy.
This trial is testing a specialized diet for people with multiple sclerosis (MS) who are not too severely disabled. You may be able to join if you have mild to moderate MS and do not have a diagnosed digestive disorder.
This trial tests whether following a Mediterranean diet can improve quality of life for people with multiple sclerosis (MS). It aims to find a dietary approach that may help manage symptoms and improve well-being.
This study tests whether N-acetyl cysteine (a supplement-like medicine) changes body and brain function in people with multiple sclerosis. It may help researchers understand how it affects brain chemistry and activity using special brain imaging.
This trial tests a different pre-medication for people with multiple sclerosis who get infusions of ocrelizumab, ublituximab, or rituximab. The goal is to see if it reduces reactions to the infusion.
Hear when a new Multiple sclerosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.